117 related articles for article (PubMed ID: 8863671)
1. Germ cell tumors of the testis overexpress wild-type p53.
Guillou L; Estreicher A; Chaubert P; Hurlimann J; Kurt AM; Metthez G; Iggo R; Gray AC; Jichlinski P; Leisinger HJ; Benhattar J
Am J Pathol; 1996 Oct; 149(4):1221-8. PubMed ID: 8863671
[TBL] [Abstract][Full Text] [Related]
2. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma.
Ito K; Sasano H; Matsunaga G; Sato S; Yajima A; Nasim S; Garret CT
J Pathol; 1997 Nov; 183(3):318-24. PubMed ID: 9422988
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
5. Association of JNK1 with p21waf1 and p53: modulation of JNK1 activity.
Xue Y; Ramaswamy NT; Hong X; Pelling JC
Mol Carcinog; 2003 Jan; 36(1):38-44. PubMed ID: 12503078
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
9. The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis.
Ulbright TM; Orazi A; de Riese W; de Riese C; Messemer JE; Foster RS; Donohue JP; Eble JN
Mod Pathol; 1994 Jan; 7(1):64-8. PubMed ID: 7909155
[TBL] [Abstract][Full Text] [Related]
10. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
11. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Ceballos E; Delgado MD; Gutierrez P; Richard C; Müller D; Eilers M; Ehinger M; Gullberg U; León J
Oncogene; 2000 Apr; 19(18):2194-204. PubMed ID: 10822369
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
[TBL] [Abstract][Full Text] [Related]
13. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.
Spierings DC; de Vries EG; Vellenga E; de Jong S
J Pathol; 2003 Jun; 200(2):137-48. PubMed ID: 12754734
[TBL] [Abstract][Full Text] [Related]
14. Significance of p53 expression in immature teratomas.
Charoenkwan P; Senger C; Weitzman S; Sexsmith E; Sherman CG; Malkin D; Thorner PS
Pediatr Dev Pathol; 2002; 5(5):499-507. PubMed ID: 12202994
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.
Heidenreich A; Schenkman NS; Sesterhenn IA; Mostofi KF; Moul JW; Srivastava S; Engelmann UH
APMIS; 1998 Jan; 106(1):90-9; discussion 99-100. PubMed ID: 9524567
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
Eid H; Géczi L; Mágori A; Bodrogi I; Institoris E; Bak M
Anticancer Res; 1998; 18(4C):3059-64. PubMed ID: 9713510
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of treatment response in human germ cell tumors.
Mayer F; Stoop H; Scheffer GL; Scheper R; Oosterhuis JW; Looijenga LH; Bokemeyer C
Clin Cancer Res; 2003 Feb; 9(2):767-73. PubMed ID: 12576448
[TBL] [Abstract][Full Text] [Related]
20. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
